Teva Pharmaceuticals has issued a voluntary recall of more than 580,000 bottles of prazosin hydrochloride, a commonly prescribed blood pressure medication, after routine quality testing detected a nitrosamine impurity known as N-nitroso Prazosin impurity C. According to the FDA, long-term exposure to nitrosamines above established limits may increase the risk of cancer.
The recall has been designated as Class II, meaning the likelihood of serious adverse health effects is considered remote, but temporary or medically reversible outcomes are possible. Nitrosamine-related recalls have occurred across the industry in recent years, affecting multiple manufacturers, including Pfizer, Merck, Sandoz, and Rising Pharmaceuticals.
Healthcare providers and pharmacies are encouraged to review affected product lots, notify patients as needed, and follow FDA recall instructions. A link to the official recall notice can be included here for full details and lot information.
Resource: Blood pressure medication recalled for potential cancer risk